SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-047493
Filing Date
2022-08-12
Accepted
2022-08-12 17:01:31
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_aikidopharma.htm   iXBRL 10-Q 790314
2 CERTIFICATION f10q0622ex31-1_aikidopharma.htm EX-31.1 10267
3 CERTIFICATION f10q0622ex32-1_aikidopharma.htm EX-32.1 4389
  Complete submission text file 0001213900-22-047493.txt   4542746

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aiki-20220630.xsd EX-101.SCH 67015
5 XBRL CALCULATION FILE aiki-20220630_cal.xml EX-101.CAL 31619
6 XBRL DEFINITION FILE aiki-20220630_def.xml EX-101.DEF 238814
7 XBRL LABEL FILE aiki-20220630_lab.xml EX-101.LAB 507819
8 XBRL PRESENTATION FILE aiki-20220630_pre.xml EX-101.PRE 258565
59 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_aikidopharma_htm.xml XML 480499
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-05576 | Film No.: 221161055
SIC: 8731 Services-Commercial Physical & Biological Research